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ABSTRACT
Pluripotent cells are characterized by a globally open and accessible chromatin organization that is
thought to contribute to cellular plasticity and developmental decision-making. We recently
identiﬁed the pluripotency factor Nanog as a key regulator of this form of chromatin architecture in
mouse embryonic stem cells. In particular, we demonstrated that the transcription factors Nanog
and Sall1 co-dependently mediate the epigenetic state of pericentromeric heterochromatin to
reinforce a more open and accessible organization in pluripotent cells. Here, we summarize our
main ﬁndings and place the work into a broader context. We explore how heterochromatin
domains could be targets of transcriptional networks in pluripotent cells and are coordinated with
cell state. We propose this integration may be to balance the requirement for a dynamic and plastic
chromatin organization in pluripotent cells, together with priming for a more restrictive nuclear
compartmentalization that is triggered rapidly upon lineage commitment.
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Introduction
Pluripotent cells, including embryonic stem cells
(ESCs) and cells from early-stage mouse embryos,
have a unique chromatin architecture that is char-
acterized by an unusually open and decondensed
genome.1-3 This higher-order nuclear organization
differs drastically from the chromatin distribution
that is observed in most other cell types, in which
heterochromatin domains contain highly com-
pacted chromatin that are readily discernable from
euchromatin compartments.4,5 Remarkably, rapid
compaction of the genome and reinforcement of
heterochromatin silencing are changes that occur at
the earliest stages during the transition from pluri-
potency to lineage commitment.6,7 Conversely,
remodelling of the genome that culminates in an
open and decompacted nuclear organization similar
to ESCs occurs at a late stage during reprogram-
ming and is required for the successful formation
of induced pluripotent stem cells.8,9 Despite being a
hallmark of pluripotency and thus fundamental to
an in-depth understanding of stem cell and devel-
opmental biology, the molecular mechanisms that
underpin these changes in nuclear organization are
only partially deﬁned. Additionally, why pluripo-
tent cells acquire this open and dispersed chroma-
tin conﬁguration remains unknown. Here, we
discuss our recent report that identiﬁed a role for
the core pluripotency factor Nanog in controlling
the nuclear architecture of mouse ESCs, thereby
describing a new mechanism directly connecting
cell state with higher-order genome organization.10
Nanog is required for chromatin remodelling in
pluripotent cells
Several reports had anticipated a crosstalk between the
pluripotent regulatory network and chromatin organi-
zation in ESCs. For example, the genomic targets of the
master pluripotent transcription factors (OCT4, SOX2
and NANOG) are co-occupied by proteins that directly
control chromatin condensation, such as UTF1, or that
promote chromatin looping, like the Cohesin andMedi-
ator complexes, suggesting the potential for recruitment
of chromatin remodellers by transcription factors.7,11, 12
Furthermore, the compaction of chromatin that is trig-
gered as ESCs or cells from early-stage mouse embryos
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start to exit pluripotency occurs concurrently with the
downregulation of Nanog, thus raising the possibility of
a connection between NANOG levels and chromatin
organization.13-16
To investigate the interplay between Nanog and
chromatin organization, we analyzed chromatin
architecture in a panel of pluripotent cell lines that
were engineered to express Nanog at different levels.17
Applying electron spectroscopy imaging to quantify
chromatin ﬁber density, we found that NANOG lev-
els correlated with chromatin “openness” (i.e. reduced
ﬁber density), particularly within heterochromatin
compartments. We then measured the distribution
and size of chromocentres by visualizing the hetero-
chromatic marker histone 3 lysine 9 trimethylation
(H3K9me3). We found that NANOG levels correlated
with fewer, but larger chromocentres – a distinct
organization that is highly characteristic of pluripo-
tent cells. Additionally, Nanog-deﬁcient ESCs had
compacted and reorganized heterochromatin domains
in a pattern similar to more developmentally mature
cell types such as epiblast stem cells (EpiSCs), despite
the ESCs remaining functionally undifferentiated.
This exciting ﬁnding suggested that chromatin orga-
nization and the pluripotent state could be experi-
mentally uncoupled, and therefore provide a tractable
model to study connections between the 2 pathways.
In particular, the requirement for Nanog to maintain
an open and dispersed heterochromatin organization
in pluripotent cells hinted that Nanog could be a
“sought after” link for the anticipated crosstalk
between master pluripotency factors and nuclear
organization. We further tested this hypothesis using
a more stringent assay by asking whether Nanog
could trigger heterochromatin remodelling when
ectopically expressed. We exploited the endogenous
low levels of Nanog in EpiSCs and analyzed the distri-
bution of chromatin before and after overexpression
of NANOG. Notably, forced expression of NANOG
in EpiSCs was sufﬁcient to decondense heterochroma-
tin and to redistribute chromocentres into fewer and
larger foci, similar to the distribution observed in
ESCs. Importantly, Nanog was the only pluripotency
factor tested (others included Klf2, Klf4, Esrrb,
Nr0b1, Prdm14, Dppa3, and Nr5a2) with the poten-
tial to remodel heterochromatin. Together, these
results revealed a new function for Nanog in bridging
the pluripotent state with the maintenance of an open
and decondensed nuclear architecture.
Nanog-dependent maintenance of open
pericentromeric heterochromatin in ESCs
To better understand howNanog contributes to genome
architecture, we focused on the nuclear compartments
that were most sensitive to Nanog-dependent remodel-
ling: the pericentromeric heterochromatin (PCH). PCH
are the main constituents of mouse heterochromatin
and are formed from major satellite repeats that com-
prise 10% of the genome. PCH are essential for genetic
stability and centromere formation. In most somatic
cells, PCH are transcriptionally repressed with high lev-
els of H3K9me3 and condensed chromatin ﬁbers.
Importantly, deletion of Suv39h1/2 or Dicer in somatic
cells leads to a reduction in the levels of repressivemodi-
ﬁcations within heterochromatin domains, to the tran-
scriptional upregulation of PCH and to an increase in
mitotic defects such as chromosomemissegregation.18,19
In contrast, PCH of ESCs have lower relative levels of
H3K9me3, are composed of open and decondensed
ﬁbers and are transcriptionally more active.20,21 Cru-
cially, high endogenous levels of PCH transcription in
ESCs is not associated with chromosome missegrega-
tion, suggesting that ESCs tolerate or even require a
unique PCH identity.19 As we observed aNanog-depen-
dent reorganization of PCH compartments, we rea-
soned that Nanog could have a novel role in mediating
the epigenetic state of PCH. Excitingly, we discovered
that NANOG binds directly to major satellite DNA
within PCH in ESCs and also when ectopically
expressed in EpiSCs. Additionally, we found that in
these cell types NANOG occupancy at major satellites
had a positive impact on transcription and in preserving
the open heterochromatic state of these regions through
lower levels of H3K9me3 and SUV39H1. Interestingly,
Nanog was unable to remodel PCH organization when
expressed in ﬁbroblast cells, suggesting that its function
may be restricted to early embryo or stem cell types. A
previous study showed that in mouse ﬁbroblast cells the
transcription factors PAX3 and PAX9 bind to PCH and
contribute to the establishment of their epigenetic
state.22 Together, this evidence leads us to suggest that
cell-type speciﬁc regulatory networks participate in the
establishment of distinct epigenetic states of PCH.
A new complex for the regulation of pericentromeric
heterochromatin in ESCs
At this point, it was unclear whether NANOG required
additional regulators to mediate PCH identity and
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organization in ESCs. From the literature, the hetero-
chromatin-binding transcriptional repressor SALL1
was a possible candidate as SALL1 is able to bind major
satellite DNA and to also control transcriptional activa-
tion/repression in association with NANOG in
ESCs.23,24 It was not known, however, if SALL1 has a
functional role in regulating PCH in ESCs. We con-
ﬁrmed an interaction between NANOG and SALL1 by
immunoprecipitation. We further demonstrated that
SALL1 is a cofactor required for NANOG-mediated
PCH remodelling, as deletion of Sall1 mimics the
Nanog-deﬁcient ESC phenotype, and Sall1 is also
required for NANOG-induced PCH remodelling in
EpiSCs. Importantly, deletion of either Nanog or Sall1
induced misregulation of the ESC-speciﬁc PCH state
and this occurred without loss of ESC identity as evalu-
ated by transcriptional and immunoﬂuorescent pheno-
typing. To determine which domains of NANOG are
required for heterochromatin remodelling, we ectopi-
cally expressed several truncated NANOG proteins in
EpiSCs and found that the strong C-terminal CD2
transactivator domain was necessary to remodel PCH
organization. Using a genetic trick, we were also able to
show that the NANOG CD2 domain was sufﬁcient to
initiate PCH remodelling in EpiSCs, and could do so in
the absence of SALL1. This was accomplished by fusing
NANOG–CD2 with a transcription activator-like
effector (TALE) that targets major satellite DNA,
thereby artiﬁcially recruiting NANOG–CD2 to PCH.
In sum, these results led us to propose that an open
PCH organization in ESCs is maintained co-depen-
dently by NANOG and SALl1 through regulation of
major satellites.
Our results suggest that the reduction of Nanog
expression that occurs during ESC to EpiSC transition
is sufﬁcient to trigger changes in PCH identity and
organization. As ﬂuctuations in Nanog levels can lead
to remodelling of higher-order nuclear organization,
our ﬁndings raise important consequences for the
long-term stability of ESCs and their specialized cell-
types that are derived upon differentiation. Con-
versely, as heterochromatin decompaction and endog-
enous Nanog induction are critical events that occur
at a late stage in cell reprogramming, it is possible that
these two processes might be connected in other con-
texts. It will be interesting to determine whether an
association between pluripotent state and genome
organization, similar to our ﬁndings in ESCs, are con-
served during cell reprogramming. We suggest that
this future line of work could have important applica-
tions including the improved generation of a more sta-
ble reprogrammed pluripotent cell type through
expression of factors (such as Nanog) that might be
able to increase the efﬁciency of chromatin remodel-
ling. Additionally, considering that disturbance of the
transcriptional and epigenetic state of pericentromeric
regions in somatic cells leads to mitotic errors and
genomic instability, it remains of great interest to
investigate whether there is any genetic impact as a
result of PCH misregulation that is induced upon the
deletion of Nanog or Sall1 in ESCs. Finally, it is also
important to investigate the mechanisms of hetero-
chromatin regulation in ESCs. In somatic cells, major
satellites are transcribed into long RNAs where the
forward transcript remains localized in cis and can
recruit HP1 to PCH. In turn, this is further stabilized
by SUV39H1/2 and H3K9me3, which recruit more
HP1 to create a positive reinforcement at PCH.25 The
function of pericentromeric regions could, therefore,
depend not just on their transcriptional state but also
on the type of transcripts being formed. It would be
interesting to further investigate whether the reduc-
tion of major satellite transcription observed in
Nanog-deﬁcient ESCs and in EpiSCs also affects their
transcript length; in particular if long transcripts are
generated that could initiate the accumulation of
the heterochromatic marks that we observed in these
cells.10
The silencing of noncoding loci: A controlled
requirement for pluripotency exit?
An intriguing aspect of pluripotency is its tolerance or
even requirement for an open and active epigenetic
state at heterochromatic loci. Positive regulation of
major satellite transcription and decondensed hetero-
chromatin is one of the direct outcomes of the pluri-
potency factor Nanog, interlinking pluripotency
maintenance with an open and transcriptionally per-
missive PCH. In vivo evidence also supports a likely
requirement for active pericentromeric transcription
in early development, as two-cell stage mouse embryos
display bursts of forward and reverse major satellite
transcription that were shown to be essential for chro-
mocentre formation and developmental progression
of the embryo.26 In addition, Dicer-depleted mouse
ESCs accumulate increased levels of major satellite
transcripts and, while this does not seem to impact
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their undifferentiated state, the mutant cells do have
an impaired differentiation potential as embryoid
body-like structures form but fail to differentiate.
Importantly, Dicer-depleted ESCs remain viable with
no signs of genomic instability, thereby supporting
our ﬁndings that ESCs tolerate and perhaps require an
open and transcriptionally permissive PCH state to
maintain pluripotency and viability.19,27
Strikingly, the tolerance or requirement for open
and active constitutive heterochromatin in pluripotent
cells does not seem to be exclusive to PCH. For exam-
ple, similar to PCH, telomeres in ESCs and in induced
pluripotent stem cells were shown to have a lower
density of H3K9me3 and H4K20me3 compared to dif-
ferentiated cells, resulting in a “relaxed” chromatin
state proposed to facilitate telomerase access to telo-
meres for regulation of their length.28 Equally, most
rDNA (rDNA) cassettes are active in mouse ESCs but
approximately half undergo inactivation and conden-
sation into heterochromatin in differentiated cells.
The rDNA silencing mediated by pRNA was shown to
be a crucial step for the exit from pluripotency, as
removal of the silencer pRNA retains ESCs in a plurip-
otent state with a low number of heterochromatic
loci.29 Finally, pluripotency-speciﬁc origins of replica-
tion have a curious epigenetic signature that are
enriched for pluripotency transcription factor binding
sites, such as NANOG and OCT4.30
Taken together, these ﬁndings pose an exciting
model whereby the epigenetic maintenance of open
and dynamic chromatin at constitutive heterochroma-
tin contributes to the maintenance of pluripotency
and is tightly regulated by the pluripotency network
(Fig. 1). Subsequently, disassembly of the regulatory
network including the downregulation of Nanog could
trigger the silencing of constitutive heterochromatic
loci (such as PCH, telomeres, rDNA) and expansion
of heterochromatin compartments. Interestingly, het-
erochromatin compartments form transcriptionally
repressive environments31 in differentiated cells but
not in ESCs.32 Thus, the formation of repressive het-
erochromatin compartments during the exit of pluri-
potency could contribute to or accelerate the
transcriptional repression of single copy regions.
Alternatively, rather than directly driving nuclear
organization, the stochastic “closeness” of several loci,
including PCH, followed by a preferential co-segrega-
tion of heterochromatic regions, could form the basis
for inactive nuclear compartments where repression
could be stably maintained.32
Conclusion
In conclusion, our work unveiled an important
mechanism for controlling higher-order nuclear orga-
nization in mouse ESCs. By assigning new roles to two
Figure 1. A model illustrating the importance of epigenetic regulation of noncoding PCH in mediating the balance between pluripo-
tency and priming for differentiation. The pluripotent transcription factors NANOG and SALL1 co-bind to PCH to maintain an open het-
erochromatin state in ESCs that is characterized by elevated PCH transcript levels and lower levels of repressive marks including
H3K9me3. As Nanog levels decrease upon transition to EpiSCs, PCH loci adopt an inaccessible and transcriptionally repressed epigenetic
state, triggering the formation of constitutive heterochromatic and potentially repressive nuclear compartments.
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well-known stem cell factors, we propose that Nanog
and Sall1 bridge the pluripotent state with the open
and decompacted chromatin architecture that deﬁnes
pluripotent cells. This unexpected control of PCH
chromatin state could contribute to the understanding
of epigenetic regulation of other processes important
for genome function. Finally, by suggesting that the
regulation of heterochromatin is tightly controlled by
the pluripotency network, we strengthen a potential
role for noncoding loci in the modulation of higher-
order chromatin organization during development
and stem cell differentiation.
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